A pharmacodynamic model for cell-cycle-specific chemotherapeutic agents
- 233 Downloads
A pharmacodynamic model is proposed and equations are developed for the quantitative analysis of dose-time-cell-survival curves produced by the administration of cell-cycle-specific chemo-therapeutic agents. The essential feature of the model is an irreversible, bimolecular mechanism of drug-receptor interaction which serves as the interface between the pharmacokinetics of the drug and the cell-cycle-cell-proliferation kinetics of the normal and neoplastic cells. A preliminary cell system which allows adequate characterization of the experimental data is a two-compartment model where cells are assumed to exist in their proliferative and nonproliferative phases. The chemotherapeutic model was used to analyze dose-time-cell-survival curves found in the literature for the effects of vincristine, vinblastine, arabinosylcytosine, and cyclophosphamide on lymphoma and hematopoietic cells in the mouse femur. Similarity in the values of the “cell-kill” constants for these drugs on the two cell types indicates that, in the cell systems studied, the proliferative state of the cells is the primary in vivodeterminant of selective chemotherapy.
Key wordspharmacokinetics cancer chemotherapy pharmacodynamics cell kinetics vincristine vinblastine arabinosylcytosine cyclophosphamide
Unable to display preview. Download preview PDF.
- 1.H. E. Skipper. The cell cycle and chemotherapy of cancer. In R. Baserga (ed.),The Cell Cycle and Cancer, Marcel Dekker, New York, pp. 358–387 (1971).Google Scholar
- 4.L. Simpson-Herren, and H. H. Lloyd. Kinetic parameters and growth curves for experimental tumor systems.Cancer Chemotherap. Rep. Part 1,54, 143–174 (1970).Google Scholar
- 6.IBM Scientific Subroutine RKGS, 360A-CM-03X, Version III. IBM Technical Publications Department, White Plains, N.Y. (1968).Google Scholar
- 9.W. R. Bruce, B. E. Meeker, W. E. Powers, and F. A. Valeriote. Comparison of the dose-and time-survival curves for normal hematopoietic and lymphoma colony-forming cells exposed to vinblastine, vincristine, arabinosylcytosine, and amethopterin.J. Natl. Cancer Inst.,42, 1015–1023 (1969).PubMedGoogle Scholar
- 10.W. R. Bruce, and F. A. Valeriote. Normal and malignant stem cells and chemotherapy.Ann. Symp. Fund. Cancer Res., pp. 409–122 (1967).Google Scholar
- 11.C. M. Metzler. NONLIN. Technical Report No. 7292/69/7293/005, Upjohn, Kalamazoo, Mich. (1969).Google Scholar
- 13.K. B. Bischoff, K. J. Himmelstein, R. L. Dedrick, and D. S. Zaharko. Pharmacokinetics and cell population growth models in cancer chemotherapy.ACS Advan. Chem., in press (1972).Google Scholar